Shareholding disclosure

ADDEX THERAPEUTICS LTD

Declared position

12.64%

Threshold

Crossed downwards

Timeline

Published

07.03.2017

Transaction

27.02.2017

Voting rights breakdown

Voting rights acquired2.33%

Voting rights sold12.64%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAH3300060

Beneficial owner

ADDEX THERAPEUTICS LTD

Declared address

ADDEX THERAPEUTICS LTD, 1228 PLAN-LES-OUATES

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

ADDEX THERAPEUTICS LTD

Addex Therapeutics Ltd07.03.2017TAH3300060

Disclosure summary

ADDEX THERAPEUTICS LTD disclosed a holding in Addex Therapeutics Ltd on the disposal side, published by SIX Exchange Regulation on 07.03.2017, at 12.64% of voting rights. Notice category: Single shareholder.

Disclosed position

12.64%

Voting rights sold

Voting rights acquired2.33%

Voting rights sold12.64%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

ADDEX THERAPEUTICS LTD disclosed a holding in Addex Therapeutics Ltd, published on 07.03.2017.

Publication date07.03.2017

Transaction date27.02.2017

Issuing companyAddex Therapeutics Ltd

Beneficial ownerADDEX THERAPEUTICS LTD

Declared addressADDEX THERAPEUTICS LTD, 1228 PLAN-LES-OUATES

CategorySingle shareholder

Voting rights acquired2.33%

Voting rights sold12.64%

Below threshold0%

ExchangeXSWX

Notification IDTAH3300060

Commercial register

CHE-113.514.094

Registered

Zefix record

Source: SIX Exchange Regulation · Publication date: 07.03.2017

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open